Recent developments in the field include an evolving treatment landscape and the development of evidence-based guidelines.

becoming the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years, and launched a few weeks later. Third-quarter sales of $6 ...

However, biologics like Dupixent (dupilumab) have paved the way for ... With its innovative mechanism of action and established success in asthma, Fasenra could address critical safety and ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting ... are investigating agents with different mechanisms of action to provide alternatives to the current ...

At that time Sanofi was cruising towards an important FDA approval for its Dupixent (dupilumab ... which has a different mechanism of action focused on IL-4. Incyte is also planning a US filing ...

the approval of COBENFY marks a transformative milestone as the first drug in over 30 years with a novel mechanism of action for treating schizophrenia. Combining xanomeline and trospium ...

Amid setbacks for emerging schizophrenia treatments, the approval of Cobenfy marks a transformative milestone as the first drug in over 30 years with a novel mechanism of action for treating ...

Dupixent, or Dupilumab, is an FDA-approved monoclonal antibody for the treatment of eosinophilic esophagitis, or EoE, due to esophageal inflammation. It works on the mechanism of inhibiting ... It ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached ... companies are investigating agents with different mechanisms of action to provide ...

Indications: Schizophrenia and psychosis related to Alzheimer’s disease (US) Amid setbacks for emerging schizophrenia treatments, the approval of COBENFY marks a milestone as the first drug in over 30 ...

Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell ...